Portfolio company
CardiaTec Biosciences
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops an artificial intelligence platform to identify cardiovascular drug targets for pharmaceutical providers using large-scale multi-omics data.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Cardiatec
This company develops an artificial intelligence platform to identify novel drug targets and therapeutics for cardiovascular diseases for the pharmaceutical and healthcare industries.
Cardiatech Bio
The company develops a computational platform to discover cardiovascular drug targets using multi-omics data for the pharmaceutical and biotechnology industries.
Cardisio
This company develops non-invasive screening technology using artificial intelligence and vectorcardiography to detect heart diseases for healthcare professionals and clinical practices.
Cardiovolt.ai
This company develops artificial intelligence models that analyse standard electrocardiograms to detect hidden cardiac and non-cardiac diseases for healthcare providers.
Cardior
This company develops RNA-based therapeutics designed to prevent, repair and reverse heart diseases for patients with cardiac dysfunctions.
Multiomic Health
This company develops an artificial intelligence platform for discovering precision medicines and biomarkers for patients with metabolic syndrome-related chronic diseases.
Preview Health
This company develops an artificial intelligence molecular profiling platform to help pharmaceutical companies and clinicians detect diseases and evaluate drug responses through biological samples.
Cartography Biosciences
This deep-tech company develops precision cancer therapeutics and drug targets for healthcare providers using computational biology and machine learning platforms.
